Synlett 2013; 24(16): 2045-2048
DOI: 10.1055/s-0033-1339676
letter
© Georg Thieme Verlag Stuttgart · New York

The Role of Ni-Carboxylate During Catalytic Asymmetric Iodolactonization Using PyBidine-Ni(OAc)2

Takayoshi Arai*
Department of Chemistry, Graduate School of Science, Chiba University, Inage 263-8522, Japan   Fax: +81(43)2902889   Email: tarai@faculty.chiba-u.jp
,
Satoshi Kajikawa
Department of Chemistry, Graduate School of Science, Chiba University, Inage 263-8522, Japan   Fax: +81(43)2902889   Email: tarai@faculty.chiba-u.jp
,
Eri Matsumura
Department of Chemistry, Graduate School of Science, Chiba University, Inage 263-8522, Japan   Fax: +81(43)2902889   Email: tarai@faculty.chiba-u.jp
› Author Affiliations
Further Information

Publication History

Received: 09 July 2013

Accepted after revision: 01 August 2013

Publication Date:
28 August 2013 (online)


Abstract

The combination of a PyBidine-Ni(OAc)2 complex with a catalytic amount of iodine efficiently catalyzed asymmetric iodo­lactonization to generate chiral iodolactones with up to 89% enantiomeric excess. The formation of an intermediate Ni-carboxylate species from the alkenyl carboxylic acid is a key role in promoting the iodolactonization.

Supporting Information

 
  • References and Notes

    • 1a Dowle MD, Davies DI. Chem. Soc. Rev. 1979; 8: 171
    • 1b Ranganathan S, Muraleedharan KM, Vaish NK, Jayaraman N. Tetrahedron 2004; 60: 5273
    • 1c Lava MS, Banerjee AK, Cabrera EV. Curr. Org. Chem. 2009; 13: 720
    • 1d Rodriguez F, Fananas FJ In Handbook of Cyclization Reactions . Vol. 4. Ma S. Wiley-VCH; Weinheim: 2010: 951
    • 1e Gribble GW. Chem. Soc. Rev. 1999; 28: 335

      For reviews of enantioselective halocyclizations, see:
    • 2a Chen G, Ma S. Angew. Chem. Int. Ed. 2010; 49: 8306
    • 2b Tan CK, Zhou L, Yeung Y. Synlett 2011; 1335
    • 2c Snyder SA, Treitler DS, Brucks AP. Aldrichimica Acta 2011; 44: 27
    • 2d Denmark SE, Kuester WE, Burk MT. Angew. Chem. Int. Ed. 2012; 51: 10938
  • 3 Kitagawa O, Hanano T, Tanabe K, Shiro M, Taguchi T. J. Chem. Soc., Chem. Commun. 1992; 1005

    • For selected examples of reagent-controlled halolactonization, see:
    • 4a Grossman RB, Trupp RJ. Can. J. Chem. 1998; 76: 1233
    • 4b Garnier JM, Robin S, Rousseau G. Eur. J. Org. Chem. 2007; 3281
  • 5 Veitch GE, Jacobsen EN. Angew. Chem. Int. Ed. 2010; 49: 7332
  • 6 Dobish MC, Johnston JN. J. Am. Chem. Soc. 2012; 134: 6068

    • For other catalytic asymmetric iodolactonizations, see:
    • 7a Wang M, Gao LX, Yue W, Mai WP. Synth. Commun. 2004; 34: 1023
    • 7b Uyanik M, Yasui T, Ishihara K. Bioorg. Med. Chem. Lett. 2009; 19: 3848
    • 7c Tungen JE, Nolsøe Hansen TV. Org. Lett. 2012; 14: 5884
    • 8a Whitehead DC, Yousefi R, Jaganathan A, Borhan B. J. Am. Chem. Soc. 2010; 132: 3298
    • 8b Yousefi R, Whitehead DC, Mueller JM, Staples RJ, Borhan B. Org. Lett. 2011; 13: 608
    • 8c Zhang W, Liu N, Schienebeck CM, Decloux K, Zheng S, Werness JB, Tang W. Chem. Eur. J. 2012; 18: 7296
    • 9a Zhang W, Zheng S, Liu N, Werness JB, Guzei IA, Tang W. J. Am. Chem. Soc. 2010; 132: 3664
    • 9b Murai K, Matsushita T, Nakamura A, Fukushima S, Shimura M, Fujioka H. Angew. Chem. Int. Ed. 2010; 49: 9174
    • 9c Zhou L, Tan CK, Jiang X, Chen F, Yeung Y.-Y. J. Am. Chem. Soc. 2010; 132: 15474
    • 9d Tan CK, Zhou L, Yeung Y.-Y. Org. Lett. 2011; 13: 2738
    • 9e Tan CT, Le C, Yeung Y. Chem. Commun. 2012; 48: 5793
    • 9f Paull DH, Fang C, Donald JR, Pansick AD, Martin SP. J. Am. Chem. Soc. 2012; 134: 11128
    • 9g Jiang X, Tan CK, Zhou L, Yueng Y. Angew. Chem. Int. Ed. 2012; 51: 7771
    • 9h Murai K, Nakamura A, Matsushita T, Shimura M, Fujioka H. Chem. Eur. J. 2012; 18: 8448 ; see also ref. 8c
  • 10 Ning Z, Jin R, Ding J, Gao L. Synlett 2009; 2291
    • 11a Arai T, Mishiro A, Yokoyama N, Suzuki K, Sato H. J. Am. Chem. Soc. 2010; 132: 5338
    • 11b Arai T, Mishiro A, Matsumura E, Awata A, Shirasugi M. Chem. Eur. J. 2012; 18: 11219
    • 11c Arai T, Ogino Y. Molecules 2012; 17: 6170
  • 12 Bhor S, Anilkumar G, Tse MK, Klawonn M, Döbler C, Bitterlich B, Grotevendt A, Beller M. Org. Lett. 2005; 7: 3373
  • 13 Recently, in the catalytic asymmetric bromolactonization using BINAP-Pd complex, the generation of a palladium-carboxylate was proposed, although the basis of metal-carboxylate formation is unclear. See: Lee HJ, Kim DY. Tetrahedron Lett. 2012; 53: 6984
  • 14 Analytical data for 2a: Rf = 0.40 (hexane–EtOAc, 2:1). 1H NMR (500 MHz, CDCl3): δ = 7.41–7.33 (m, 5 H), 3.58 (dd, J = 12.3, 11.2 Hz, 2 H), 2.57–2.33 (m, 4 H), 1.84–1.80 (m, 1 H), 1.60–1.56 (m, 1 H); 13C NMR (125 MHz, CDCl3): δ = 170.5, 140.3, 129.1, 128.5, 125.3, 84.5, 32.1, 29.1, 17.8, 16.6; HRMS: m/z [M + H]+ calcd for C12H14O2I: 317.0033; found: 317.0031; 78% ee; [α]D 24 +27.5 (c = 1.2, CHCl3); enantiomeric excess was determined by HPLC analysis with a Chiralpak AD-H column (hexane–i-PrOH, 95:5; 1.0 mL/min; 250 nm): R t = 14.2 (major enantiomer), 15.8 (minor enantiomer) min.
  • 15 Enantioselective Iodolactonization Catalyzed by PyBidine-Ni(OAc)2 Complex; General Procedure: A mixture of PyBidine (7.3 mg, 0.0105 mmol) and Ni(OAc)2·4H2O (2.5 mg 0.01 mmol) was stirred at r.t. for 3 h in anhydrous CH2Cl2 (1.0 mL). After cooling the mixture to –78 °C, a carboxylic acid (0.1 mmol) in toluene (3.0 mL) was slowly added and the mixture was stirred for 0.5 h at the same temperature. I2 (5.0 mg, 0.02 mmol) and NIS (24.6 mg, 0.11 mmol) were added and the mixture was stirred for 22–48 h. The reaction was quenched by the addition of saturated aq Na2SO3 and 1 M aq NaOH, and extracted with CH2Cl2 (3×). The collected organic layer was dried over Na2SO4. After removal of the solvent under reduced pressure, the residue was purified by silica-gel column chromatography (hexane–EtOAc, 6:1) to afford the iodolactone. The enantiomeric excess of the product was determined by HPLC analysis.